KAZIA THERAPEUTICS LTD - KZIA

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$17.06M
QoQ value delta ($000)
+$15.93M (+1402.11%)
Implied price effect (QoQ)
-4.24%
Shares
Total shares
2,479,478
QoQ shares delta
+2,321,404 (+1468.56%)
Total shares held by funds (by quarter)

Market chart (KZIA)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q1 2026 data: only 2 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Alyeska Investment Group, L.P. 5,087 738,321 0.01%
Stonepine Capital Management, LLC 3,171 460,359 2.32%
Bleichroeder LP 2,756 400,000 0.48%
Velan Capital Investment Management LP 2,067 300,000 1.2%
Point72 Asset Management, L.P. 1,378 200,000 0.0%
Empery Asset Management, LP 1,171 170,000 1.03%
CORSAIR CAPITAL MANAGEMENT, L.P. 470 70,000 0.07%
ROYAL BANK OF CANADA 373 54,133 0.0%
Westside Investment Management, Inc. 212 30,875 0.03%
BARCLAYS PLC 165 23,999 0.0%
Rockefeller Capital Management L.P. 73 10,700 0.0%
Engineers Gate Manager LP 71 10,388 0.0%
FNY Investment Advisers, LLC 51 7,500 0.01%
RHUMBLINE ADVISERS 10 1,565 0.0%
MORGAN STANLEY 6 1,000 0.0%
Arax Advisory Partners 1 200 0.0%
UBS Group AG 1 193 0.0%
GAMMA Investing LLC 1 232 0.0%
CITIGROUP INC 0 1 0.0%
Allworth Financial LP 0 1 0.0%
OSAIC HOLDINGS, INC. 0 10 0.0%
Dauntless Investment Group, LLC 0 1 0.0%